(Q33994217)

30 July 2017

Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study (English)

1 reference

Anne-Catherine Bachoud-Lévi

30 July 2017

0 references

1

Anne-Catherine Bachoud-Lévi

0 references

Philippe Remy

Philippe Remy

10

0 references

Philippe Hantraye

12

Philippe Hantraye

1 reference

30 July 2017

2

Véronique Gaura

1 reference

30 July 2017

Jean-Pascal Lefaucheur

4

Jean-Pascal Lefaucheur

1 reference

30 July 2017

Marie-Françoise Boissé

5

Marie-Françoise Boissé

1 reference

30 July 2017

7

Sophie Baudic

1 reference

30 July 2017

8

Maria-Joao Ribeiro

1 reference

30 July 2017

9

Catherine Bourdet

1 reference

30 July 2017

11

Pierre Cesaro

1 reference

30 July 2017

13

Marc Peschanski

1 reference

30 July 2017

Pierre Brugières

3

1 reference

30 July 2017

Patrick Maison

6

1 reference

30 July 2017

1 April 2006

1 reference

30 July 2017

1 reference

30 July 2017

5

1 reference

30 July 2017

4

1 reference

30 July 2017

303-309

1 reference

Striatal neural grafting improves cortical metabolism in Huntington's disease patients

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970381-7

7 January 2021

Motor and cognitive improvements in patients with Huntington's disease after neural transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970381-7

7 January 2021

Fetal neural grafts for Huntington's disease: a prospective view

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970381-7

7 January 2021

Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970381-7

7 January 2021

First step towards cell therapy for Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970381-7

7 January 2021

Integrating fetal neural transplants into a therapeutic strategy: the example of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970381-7

7 January 2021

Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970381-7

7 January 2021

Bilateral human fetal striatal transplantation in Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970381-7

7 January 2021

Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970381-7

7 January 2021

Unified Huntington's disease rating scale: Reliability and consistency

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970381-7

7 January 2021

Retest effects and cognitive decline in longitudinal follow-up of patients with early HD.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970381-7

7 January 2021

Age-associated changes of cerebral glucose metabolic activity in both male and female deaf children: parametric analysis using objective volume of interest and voxel-based mapping

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970381-7

7 January 2021

Rate of functional decline in Huntington's disease. Huntington Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970381-7

7 January 2021

Influence of lamotrigine on progression of early Huntington disease: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970381-7

7 January 2021

A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970381-7

7 January 2021

Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970381-7

7 January 2021

Positron emission tomography after fetal transplantation in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970381-7

7 January 2021

Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970381-7

7 January 2021

Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970381-7

7 January 2021

10.1016/S1474-4422(06)70381-7

Identifiers

DOI

1 reference

30 July 2017

1 reference